Disease Modeling & Screening Platform

Medicine & Life Sciences

1. Parkinson Disease 100%
2. alpha-Synuclein 98%
3. HIV-1 97%
4. Preclinical Drug Evaluations 62%
5. C Chemokines 57%
6. Organoids 48%
7. CXC Chemokines 47%
8. CC Chemokines 47%
9. Mutation 45%
10. Tropism 44%
11. Carcinoid Tumor 42%
12. Chemokine Receptors 41%
13. Point Mutation 41%
14. Genes 40%
15. Cell Line 39%
16. Glioblastoma 36%
17. Dopaminergic Neurons 34%
18. Viruses 33%
19. Mitochondria 30%
20. Clone Cells 29%
21. Maraviroc 29%
22. Virion 28%
23. Induced Pluripotent Stem Cells 25%
24. Germ Layers 25%
25. Neoplasms 24%
26. Peptides 23%
27. Clustered Regularly Interspaced Short Palindromic Repeats 23%
28. Virus Internalization 23%
29. Neurons 22%
30. Drug Therapy 21%
31. Lung 19%
32. Mesencephalon 18%
33. Bacteriophages 18%
34. T-Lymphocytes 17%
35. Phenotype 17%
36. Neuroendocrine Tumors 16%
37. Pharmaceutical Preparations 16%
38. Pleural Effusion 15%
39. Genotype 15%
40. Therapeutics 14%
41. Neoplasm Metastasis 13%
42. Retroviridae 13%
43. cediranib 12%
44. Proteins 12%
45. Transgenes 12%
46. Parkinson Disease, Familial, Type 1 11%
47. Liver 11%
48. Investigational Drugs 10%
49. Macrophages 10%
50. Rotenone 9%
51. Limit of Detection 9%
52. Technology 9%
53. Capecitabine 9%
54. Fibroblasts 9%
55. Pleura 8%
56. Viral Genes 8%
57. Luciferases 8%
58. Viral Envelope Proteins 8%
59. HIV 8%
60. Bevacizumab 8%
61. Drug Discovery 7%
62. Karyotype 7%
63. Virus Replication 7%
64. Infections 7%
65. United States Food and Drug Administration 7%
66. Lipid Metabolism 7%
67. Skin 6%
68. Mitochondrial Diseases 6%
69. Libraries 6%
70. Humoral Immunity 6%
71. CD4 Lymphocyte Count 6%
72. Alanine 6%
73. Cations 6%
74. Neutralizing Antibodies 6%
75. Respiration 6%
76. Machine Learning 6%
77. Lung Neoplasms 5%
78. Flow Cytometry 5%
79. Vaccines 5%
80. Immunoglobulin M 5%
81. HIV Infections 5%
82. In Vitro Techniques 5%
83. Epitopes 5%
84. Antiviral Agents 5%
85. Ganglia 5%
86. Organelles 5%